KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Net Margin: 2009-2025

Historic Net Margin for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to 7.60%.

  • Quest Diagnostics' Net Margin fell 40.00% to 7.60% in Q3 2025 from the same period last year, while for Sep 2025 it was 7.78%, marking a year-over-year increase of 18.00%. This contributed to the annual value of 8.78% for FY2024, which is 37.00% down from last year.
  • Latest data reveals that Quest Diagnostics reported Net Margin of 7.60% as of Q3 2025, which was down 16.07% from 9.05% recorded in Q2 2025.
  • Quest Diagnostics' 5-year Net Margin high stood at 23.49% for Q2 2021, and its period low was 3.26% during Q4 2022.
  • Its 3-year average for Net Margin is 7.82%, with a median of 7.60% in 2025.
  • In the last 5 years, Quest Diagnostics' Net Margin surged by 1,588bps in 2021 and then tumbled by 1,505bps in 2022.
  • Quest Diagnostics' Net Margin (Quarterly) stood at 12.72% in 2021, then crashed by 946bps to 3.26% in 2022, then soared by 382bps to 7.08% in 2023, then soared by 40bps to 7.48% in 2024, then plummeted by 40bps to 7.60% in 2025.
  • Its Net Margin was 7.60% in Q3 2025, compared to 9.05% in Q2 2025 and 6.94% in Q1 2025.